Clinical Correlations

The NYU Langone Online Journal of Medicine


LATEST POSTS

The Fentanyl Crisis

By Andrew Segoshi

Peer Reviewed

If you live in New York, you’ve no doubt encountered the opioid epidemic sweeping the nation in the past decade. Whether it’s firsthand experience passing opioid users in the street congregating on St. Mark’s every summer, hearing shocking news stories like the recent 70+ person overdose this past August in a park in New Haven (attributed to K2 laced with opioids),1 or noticing the uptick in celebrity overdose stories, it’s becoming increasingly hard to ignore this national problem.…

Read More

Metformin’s Role in Type 1 Diabetes: the REMOVAL Trial

By William Plowe

Peer Reviewed

Metformin has been the first-line drug in type 2 diabetes for over a decade, but its possible benefit in type 1 diabetes (DM1) is still a matter of study. The American Diabetes Association lists metformin as an investigational agent that may reduce insulin requirements in DM1, but it is not FDA-approved for that use.…

Read More

How Far Should We Search for Malignancy in the Seemingly “Unprovoked” Venous Thromboembolism?

By Allison Guttmann, MD

Peer Reviewed

A middle-aged woman presents to the Emergency Department with 1 week of calf-pain and swelling. A venous duplex ultrasound reveals a non-compressible popliteal vein suggestive of deep venous thrombosis (DVT). After the diagnosis has been established, we run through our checklist of follow-up questions:

Have you undergone recent surgery?…

Read More

Primecuts – This Week in the Journals

By Roisin Finan MD

Peer Reviewed

With medicine advancing at such a rapid pace, it is crucial for physicians to keep up with the medical literature.  This can quickly become an overwhelming endeavor given the sheer quantity and breadth of literature released on a daily basis.…

Read More

Does CPAP Ameliorate the Risk of Cardiovascular Events in Patients with Obstructive Sleep Apnea?

By Gregory Rubinfeld, MD

Peer Reviewed

Obstructive sleep apnea (OSA) is an increasingly prevalent disorder that has well described associations with cardiovascular disease. OSA affects approximately 20–30% of males and 10–15% of females in North America.1-3 In addition to male gender, other risk factors for OSA include obesity, older age, and hypertension.…

Read More